<p>联合资本金融顾问公司在最近向证券交易委员会提交的 13F 文件中表示，在第四季度将其在美敦力公司的股份增加了 19.9%。该基金在季度内购买了 77,010 股后，持有 464,436 股这家医疗技术公司的股票。根据其最近的 SEC 文件，联合资本金融顾问公司在美敦力的持股价值为 37,099,000 美元。</p>
<ul>
<li>MarketBeat 周报 – 02/17 - 02/21</li>
</ul>
<p>其他几家对冲基金和机构投资者也对该公司的持仓进行了调整。Copley Financial Group Inc.在第三季度新购入了美敦力的股份，价值约为 694,000 美元。Franklin Street Advisors Inc. NC 在第四季度将其在美敦力的持股增加了 32.6%。Franklin Street Advisors Inc. NC 目前拥有 73,517 股这家医疗技术公司的股票，价值为 5,873,000 美元，此前在上个季度又购买了 18,057 股。Olstein Capital Management L.P.在第四季度将其在美敦力的持仓提高了 8.0%。Olstein Capital Management L.P.目前拥有 94,000 股这家医疗技术公司的股票，价值为 7,509,000 美元，此前在该期间又购买了 7,000 股。捷克国家银行在第四季度将其在美敦力的持仓提高了 6.4%。捷克国家银行目前拥有 278,065 股这家医疗技术公司的股票，价值为 22,212,000 美元，此前在该期间又购买了 16,786 股。最后，Empowered Funds LLC 在第四季度将其在美敦力的股份提高了 2.7%。Empowered Funds LLC 目前拥有 105,822 股这家医疗技术公司的股票，价值为 8,453,000 美元，此前在上个季度又购买了 2,778 股。82.06% 的股票由机构投资者持有。</p>
<h2>美敦力价格表现</h2>
<p>美敦力（NYSE:MDT）周二开盘价为 84.20 美元。该公司的市值为 1,079.9 亿美元，市盈率为 25.59，市盈增长比率为 2.22，贝塔值为 0.79。该公司的 50 日简单移动平均为 89.56 美元，200 日简单移动平均为 87.60 美元。该公司的速动比率为 1.39，流动比率为 1.90，债务与股本比率为 0.48。美敦力的 12 个月低点为 75.96 美元，12 个月高点为 96.25 美元。</p>
<ul>
<li>美敦力的扩张势头增强——市场转变的时机到了吗？</li>
</ul>
<p>美敦力（NYSE:MDT - 获取免费报告）最近于 2 月 18 日发布了其财报。这家医疗技术公司报告第四季度每股收益为 1.39 美元，超出分析师一致预期的 1.36 美元，超出幅度为 0.03 美元。该季度的收入为 82.9 亿美元，而分析师预期为 83.3 亿美元。美敦力的净利润率为 12.83%，股本回报率为 14.07%。卖方分析师平均预测美敦力在当前年度的每股收益为 5.46。</p>
<h2>美敦力宣布分红</h2>
<p>该公司最近还披露了季度分红，已于 4 月 11 日（星期五）支付。3 月 28 日（星期五）的股东获得每股 0.70 美元的分红。这相当于年化分红为 2.80 美元，收益率为 3.33%。该分红的除息日为 3 月 28 日（星期五）。美敦力的分红支付比率为 85.11%。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>直觉外科在机器人手术创新中领先</li>
</ul>
<p>多位研究分析师对 MDT 股票发表了评论。Truist Financial 将美敦力的目标价从 93.00 美元下调至 90.00 美元，并在周五的报告中对该股票给予 “持有” 评级。Robert W. Baird 在 2 月 19 日的报告中将美敦力的目标价从 90.00 美元上调至 91.00 美元，并给予该股票 “中性” 评级。加拿大皇家银行在 2 月 19 日的研究报告中重申了 “跑赢大盘” 评级，并对美敦力的股票设定了 105.00 美元的目标价。Needham &amp; Company LLC 在 2 月 19 日的研究报告中重申了对美敦力的 “持有” 评级。最后，花旗集团在 3 月 4 日的研究报告中将美敦力的评级从 “中性” 上调至 “买入”，并将该股票的目标价从 92.00 美元上调至 107.00 美元。一位研究分析师对该股票给予了 “卖出” 评级，八位分析师给予 “持有” 评级，六位分析师给予 “买入” 评级，还有一位分析师给予 “强烈买入” 评级。根据 MarketBeat.com 的数据，美敦力目前的共识评级为 “持有”，平均目标价为 96.14 美元。</p>
<p><strong>查看我们对美敦力的最新股票分析</strong></p>
<h2>内部活动</h2>
<p>在其他消息中，执行副总裁 Brett A. Wall 于 1 月 24 日（星期五）出售了 12,437 股公司的股票，交易价格为 90.00 美元，总价值为 1,119,330.00 美元。交易完成后，该执行副总裁目前直接持有 40,979 股公司的股票，价值为 3,688,110 美元。这代表其持股减少了 23.28%。该交易已在 SEC 的法律文件中披露，相关文件可通过此链接获取。当前 0.20% 的股票由公司内部人士持有。</p>
<h2>美敦力公司简介</h2>
<p>（免费报告）</p>
<p>美敦力公司开发、制造和销售基于设备的医疗疗法，服务于全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票，胜过美敦力</li>
<li>什么是欧洲 STOXX 50 指数？</li>
<li>交易员再次开始押注 PayPal 的反弹</li>
<li>什么是国债？</li>
<li>黑石是否在暗示尽管有新关税市场仍将反弹？</li>
<li>如何购买黄金股票并投资黄金</li>
<li>微软：在关税担忧中兼具增长与价值</li>
</ul>
<p><strong>想看看其他对美敦力持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com 获取美敦力公司（NYSE:MDT - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在美敦力吗？</h2>
<p>在考虑美敦力之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而美敦力并不在名单上。</p>
<p>虽然美敦力目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

美敦力

<p>United Capital Financial Advisors LLC 在第四季度将其在美敦力（Medtronic plc，NYSE:MDT）的持股增加了 19.9%，目前持有 464,436 股，价值 3710 万美元。其他机构投资者也调整了他们的持仓，其中富兰克林街顾问公司（Franklin Street Advisors）和奥尔斯坦资本管理公司（Olstein Capital Management）显著增加了持股。美敦力的股票开盘价为 84.20 美元，市值为 1079.9 亿美元。该公司报告每股收益为 1.39 美元，超出预期，并宣布季度股息为每股 0.70 美元。分析师对该股票的评级不一，普遍评级为 “持有”</p>

<p>United Capital Financial Advisors LLC increased its stake in Medtronic plc (NYSE:MDT - Free Report) by 19.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 464,436 shares of the medical technology company's stock after buying an additional 77,010 shares during the quarter. United Capital Financial Advisors LLC's holdings in Medtronic were worth $37,099,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>联合资本金融顾问公司在最近向证券交易委员会提交的 13F 文件中表示，在第四季度将其在美敦力公司的股份增加了 19.9%。该基金在季度内购买了 77,010 股后，持有 464,436 股这家医疗技术公司的股票。根据其最近的 SEC 文件，联合资本金融顾问公司在美敦力的持股价值为 37,099,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 02/17 - 02/21</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also made changes to their positions in the company. Copley Financial Group Inc. acquired a new position in shares of Medtronic during the 3rd quarter worth approximately $694,000. Franklin Street Advisors Inc. NC increased its holdings in shares of Medtronic by 32.6% in the fourth quarter. Franklin Street Advisors Inc. NC now owns 73,517 shares of the medical technology company's stock valued at $5,873,000 after purchasing an additional 18,057 shares during the last quarter. Olstein Capital Management L.P. raised its position in shares of Medtronic by 8.0% in the fourth quarter. Olstein Capital Management L.P. now owns 94,000 shares of the medical technology company's stock valued at $7,509,000 after purchasing an additional 7,000 shares during the period. Czech National Bank raised its position in shares of Medtronic by 6.4% in the fourth quarter. Czech National Bank now owns 278,065 shares of the medical technology company's stock valued at $22,212,000 after purchasing an additional 16,786 shares during the period. Finally, Empowered Funds LLC lifted its stake in shares of Medtronic by 2.7% during the 4th quarter. Empowered Funds LLC now owns 105,822 shares of the medical technology company's stock worth $8,453,000 after buying an additional 2,778 shares during the last quarter. 82.06% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者也对该公司的持仓进行了调整。Copley Financial Group Inc.在第三季度新购入了美敦力的股份，价值约为 694,000 美元。Franklin Street Advisors Inc. NC 在第四季度将其在美敦力的持股增加了 32.6%。Franklin Street Advisors Inc. NC 目前拥有 73,517 股这家医疗技术公司的股票，价值为 5,873,000 美元，此前在上个季度又购买了 18,057 股。Olstein Capital Management L.P.在第四季度将其在美敦力的持仓提高了 8.0%。Olstein Capital Management L.P.目前拥有 94,000 股这家医疗技术公司的股票，价值为 7,509,000 美元，此前在该期间又购买了 7,000 股。捷克国家银行在第四季度将其在美敦力的持仓提高了 6.4%。捷克国家银行目前拥有 278,065 股这家医疗技术公司的股票，价值为 22,212,000 美元，此前在该期间又购买了 16,786 股。最后，Empowered Funds LLC 在第四季度将其在美敦力的股份提高了 2.7%。Empowered Funds LLC 目前拥有 105,822 股这家医疗技术公司的股票，价值为 8,453,000 美元，此前在上个季度又购买了 2,778 股。82.06% 的股票由机构投资者持有。</p>
</div><h2>Medtronic Price Performance</h2>
<div class="lb-trans"><h2>美敦力价格表现</h2>
</div><p>Shares of NYSE MDT opened at $84.20 on Tuesday. The company has a market capitalization of $107.99 billion, a PE ratio of 25.59, a P/E/G ratio of 2.22 and a beta of 0.79. The firm has a fifty day simple moving average of $89.56 and a 200 day simple moving average of $87.60. The company has a quick ratio of 1.39, a current ratio of 1.90 and a debt-to-equity ratio of 0.48. Medtronic plc has a twelve month low of $75.96 and a twelve month high of $96.25.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT）周二开盘价为 84.20 美元。该公司的市值为 1,079.9 亿美元，市盈率为 25.59，市盈增长比率为 2.22，贝塔值为 0.79。该公司的 50 日简单移动平均为 89.56 美元，200 日简单移动平均为 87.60 美元。该公司的速动比率为 1.39，流动比率为 1.90，债务与股本比率为 0.48。美敦力的 12 个月低点为 75.96 美元，12 个月高点为 96.25 美元。</p>
</div><ul>
<li>Medtronic’s Expansion Gains Momentum—Time for a Market Shift?</li>
</ul>
<div class="lb-trans"><ul>
<li>美敦力的扩张势头增强——市场转变的时机到了吗？</li>
</ul>
</div><p>Medtronic (NYSE:MDT - Get Free Report) last posted its earnings results on Tuesday, February 18th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.03. The company had revenue of $8.29 billion for the quarter, compared to analyst estimates of $8.33 billion. Medtronic had a net margin of 12.83% and a return on equity of 14.07%. On average, sell-side analysts forecast that Medtronic plc will post 5.46 EPS for the current year.</p>
<div class="lb-trans"><p>美敦力（NYSE:MDT - 获取免费报告）最近于 2 月 18 日发布了其财报。这家医疗技术公司报告第四季度每股收益为 1.39 美元，超出分析师一致预期的 1.36 美元，超出幅度为 0.03 美元。该季度的收入为 82.9 亿美元，而分析师预期为 83.3 亿美元。美敦力的净利润率为 12.83%，股本回报率为 14.07%。卖方分析师平均预测美敦力在当前年度的每股收益为 5.46。</p>
</div><h2>Medtronic Announces Dividend</h2>
<div class="lb-trans"><h2>美敦力宣布分红</h2>
</div><p>The company also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 3.33%. The ex-dividend date of this dividend was Friday, March 28th. Medtronic's dividend payout ratio is 85.11%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，已于 4 月 11 日（星期五）支付。3 月 28 日（星期五）的股东获得每股 0.70 美元的分红。这相当于年化分红为 2.80 美元，收益率为 3.33%。该分红的除息日为 3 月 28 日（星期五）。美敦力的分红支付比率为 85.11%。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>Intuitive Surgical Leads the Pack in Robotic Surgery Innovation</li>
</ul>
<div class="lb-trans"><ul>
<li>直觉外科在机器人手术创新中领先</li>
</ul>
</div><p>A number of research analysts have commented on MDT shares. Truist Financial decreased their price objective on Medtronic from $93.00 to $90.00 and set a &#34;hold&#34; rating on the stock in a report on Friday. Robert W. Baird raised their target price on shares of Medtronic from $90.00 to $91.00 and gave the stock a &#34;neutral&#34; rating in a report on Wednesday, February 19th. Royal Bank of Canada reiterated an &#34;outperform&#34; rating and issued a $105.00 price target on shares of Medtronic in a research note on Wednesday, February 19th. Needham &amp; Company LLC reiterated a &#34;hold&#34; rating on shares of Medtronic in a research report on Wednesday, February 19th. Finally, Citigroup upgraded Medtronic from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their price target for the stock from $92.00 to $107.00 in a research report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Medtronic presently has a consensus rating of &#34;Hold&#34; and an average target price of $96.14.</p>
<div class="lb-trans"><p>多位研究分析师对 MDT 股票发表了评论。Truist Financial 将美敦力的目标价从 93.00 美元下调至 90.00 美元，并在周五的报告中对该股票给予 “持有” 评级。Robert W. Baird 在 2 月 19 日的报告中将美敦力的目标价从 90.00 美元上调至 91.00 美元，并给予该股票 “中性” 评级。加拿大皇家银行在 2 月 19 日的研究报告中重申了 “跑赢大盘” 评级，并对美敦力的股票设定了 105.00 美元的目标价。Needham &amp; Company LLC 在 2 月 19 日的研究报告中重申了对美敦力的 “持有” 评级。最后，花旗集团在 3 月 4 日的研究报告中将美敦力的评级从 “中性” 上调至 “买入”，并将该股票的目标价从 92.00 美元上调至 107.00 美元。一位研究分析师对该股票给予了 “卖出” 评级，八位分析师给予 “持有” 评级，六位分析师给予 “买入” 评级，还有一位分析师给予 “强烈买入” 评级。根据 MarketBeat.com 的数据，美敦力目前的共识评级为 “持有”，平均目标价为 96.14 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on Medtronic</strong></p>
<div class="lb-trans"><p><strong>查看我们对美敦力的最新股票分析</strong></p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><p>In other news, EVP Brett A. Wall sold 12,437 shares of the company's stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $90.00, for a total value of $1,119,330.00. Following the completion of the transaction, the executive vice president now directly owns 40,979 shares of the company's stock, valued at $3,688,110. This represents a 23.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.20% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他消息中，执行副总裁 Brett A. Wall 于 1 月 24 日（星期五）出售了 12,437 股公司的股票，交易价格为 90.00 美元，总价值为 1,119,330.00 美元。交易完成后，该执行副总裁目前直接持有 40,979 股公司的股票，价值为 3,688,110 美元。这代表其持股减少了 23.28%。该交易已在 SEC 的法律文件中披露，相关文件可通过此链接获取。当前 0.20% 的股票由公司内部人士持有。</p>
</div><h2>Medtronic Company Profile</h2>
<div class="lb-trans"><h2>美敦力公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p>
<div class="lb-trans"><p>美敦力公司开发、制造和销售基于设备的医疗疗法，服务于全球的医疗系统、医生、临床医生和患者。其心血管产品组合提供可植入的心脏起搏器、心脏复律除颤器和心脏再同步治疗设备；心脏消融产品；可植入心脏监测系统；TYRX 产品；以及远程监测和以患者为中心的软件。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Medtronic</li>
<li>What is the Euro STOXX 50 Index?</li>
<li>Traders Started Betting on PayPal's Rally Again</li>
<li>What Are Treasury Bonds?</li>
<li>Is BlackRock Signaling a Market Rally Despite New Tariffs?</li>
<li>How to Buy Gold Stock and Invest in Gold</li>
<li>Microsoft: A Blend of Growth and Value Amid Tariff Concerns</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过美敦力</li>
<li>什么是欧洲 STOXX 50 指数？</li>
<li>交易员再次开始押注 PayPal 的反弹</li>
<li>什么是国债？</li>
<li>黑石是否在暗示尽管有新关税市场仍将反弹？</li>
<li>如何购买黄金股票并投资黄金</li>
<li>微软：在关税担忧中兼具增长与价值</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc (NYSE:MDT - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对美敦力持有的对冲基金吗？</strong> 请访问 HoldingsChannel.com 获取美敦力公司（NYSE:MDT - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MDT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Medtronic Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在美敦力吗？</h2>
</div><p>Before you consider Medtronic, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑美敦力之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而美敦力并不在名单上。</p>
</div><p>While Medtronic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然美敦力目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

United Capital Financial Advisors LLC 在美敦力公司（NYSE:MDT）持有价值 3710 万美元的股票头寸